Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC

PHASE3UnknownINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

November 15, 2012

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Oropharyngeal Squamous Cell Carcinoma
Interventions
DRUG

Cisplatin

DRUG

Cetuximab

Trial Locations (33)

6

St Luke's Hospital, Dublin

Unknown

Beaumont Hospital, Dublin

VU University Medical Center, Amsterdam

Aberdeen Royal Infirmary, Aberdeen

Bradford Royal Infirmary, Bradford

Colchester General Hospital, Colchester

Castle Hill Hospital, Cottingham

Royal Derby Hospital, Derby

New Cross Hospital, New Cross

Northampton General Hospital, Northampton

Norfolk & Norwich University Hospital, Norwich

Glan Clwyd Hospital, Rhyl

Royal Shrewsbury Hospital, Shrewsbury

Royal Marsden Hospital, Sutton

Musgrove Park Hospital, Taunton

BA1 3NG

Royal United Hospital, Bath

CH63 4JY

Clatterbridge Cancer Centre, Bebington

BS2 8ED

Bristol Haematology & Oncology Centre, Bristol

CF14 2TL

Velindre Hospital, Cardiff

GL53 7AN

Cheltenham General Hospital, Cheltenham

CV2 2DX

University Hospitals Coventry & Warwickshire, Coventry

B15 2TH

Queen Elizabeth Hospital Birmingham, Edgbaston

EH4 2XU

Western General Hospital, Edinburgh

EX2 5DW

Royal Devon & Exeter Hospital, Exeter

GU2 7XX

Royal Surrey County Hospital, Guildford

LS9 7TF

St James's Institute of Oncology, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

NW1 2PG

University College Hospital, London

SW3 6JJ

Royal Marsden Hospital, London

TS4 3BW

James Cook University Hospital, Middlesbrough

NG5 1PB

Nottingham University Hopsital, Nottingham

S10 2SJ

Weston Park Hospital, Sheffield

SA2 8QA

Singleton Hospital, Swansea

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

University of Birmingham

OTHER

collaborator

University of Oxford

OTHER

lead

University of Warwick

OTHER

NCT01874171 - Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC | Biotech Hunter | Biotech Hunter